Comparison of the rho-kinase inhibitors netarsudil and ripasudil for the treatment of Fuchs endothelial corneal dystrophy

Rhopressa (netarsudil) - Alcon

Glanatec (ripasudil) - Kowa

Aditya Somisetty1,2; Jessica Skeie1,2; Hanna Shevalye1,2; Apurva Dusane3; Timothy Eggleston2; Aliasger Salem3; Mark A. Greiner1,2

May 8, 2026